Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 6412353, 14 pages
https://doi.org/10.1155/2017/6412353
Research Article

Vaccinomics Approach for Designing Potential Peptide Vaccine by Targeting Shigella spp. Serine Protease Autotransporter Subfamily Protein SigA

1Department of Biotechnology and Genetic Engineering, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh
2Biotechnology and Genetic Engineering Discipline, Life Science School, Khulna University, Khulna, Bangladesh
3Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh
4Enteric and Food Microbiology Laboratory, International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b), Dhaka, Bangladesh

Correspondence should be addressed to K. M. Kaderi Kibria; moc.oohay@airbik_mk

Received 18 March 2017; Revised 28 June 2017; Accepted 24 July 2017; Published 7 September 2017

Academic Editor: Pedro A. Reche

Copyright © 2017 Arafat Rahman Oany et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. L. Hale and G. T. Keusch, “Shigella,” in Medical Microbiology, S. Baron, Ed., University of Texas Medical Branch at Galveston, Galveston (TX), USA, 4th edition, 1996, Chapter 22. View at Google Scholar
  2. K. L. Kotloff, J. P. Winickoff, B. Ivanoff et al., “Global burden of Shigella infections: implications for vaccine development and implementation of control strategies,” Bulletin of the World Health Organization, vol. 77, no. 8, p. 651, 1999. View at Google Scholar
  3. L. von Seidlein, D. R. Kim, M. Ali et al., “A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology,” PLoS Medicine, vol. 3, no. 9, article e353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. L. Kotloff, J. P. Nataro, W. C. Blackwelder et al., “Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study,” Lancet, vol. 382, no. 9888, p. 209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Dutta, K. Rajendran, S. Roy et al., “Shifting serotypes, plasmid profile analysis and antimicrobial resistance pattern of shigellae strains isolated from Kolkata, India during 1995-2000,” Epidemiology and Infection, vol. 129, no. 2, p. 235, 2002. View at Google Scholar
  6. M. A. Salam, U. Dhar, W. A. Khan, and M. L. Bennish, “Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis,” Lancet, vol. 352, no. 9127, p. 522, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. K. A. Talukder, B. K. Khajanchi, M. A. Islam et al., “Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south Asia,” The Journal of Antimicrobial Chemotherapy, vol. 54, no. 4, p. 730, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. K. A. Talukder, B. K. Khajanchi, M. A. Islam et al., “Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1,” Current Microbiology, vol. 52, no. 2, p. 108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. I. R. Henderson, F. Navarro-Garcia, and J. P. Nataro, “The great escape: structure and function of the autotransporter proteins,” Trends in Microbiology, vol. 6, no. 9, p. 370, 1998. View at Google Scholar
  10. K. Al-Hasani, F. Navarro-Garcia, J. Huerta, H. Sakellaris, and B. Adler, “The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells,” PLoS One, vol. 4, no. 12, article e8223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Al-Hasani, I. R. Henderson, H. Sakellaris et al., “The sigA gene which is borne on the shepathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation,” Infection and Immunity, vol. 68, no. 5, p. 2457, 2000. View at Google Scholar
  12. F. Berlanda Scorza, A. M. Colucci, L. Maggiore et al., “High yield production process for Shigella outer membrane particles,” PLoS One, vol. 7, no. 6, article e35616, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Sette, M. Newman, B. Livingston et al., “Optimizing vaccine design for cellular processing, MHC binding and TCR recognition,” Tissue Antigens, vol. 59, no. 6, p. 443, 2002. View at Google Scholar
  14. G. A. Poland, I. G. Ovsyannikova, and R. M. Jacobson, “Application of pharmacogenomics to vaccines,” Pharmacogenomics, vol. 10, no. 5, p. 837, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. P. Singh and B. N. Mishra, “Major histocompatibility complex linked databases and prediction tools for designing vaccines,” Human Immunology, vol. 77, no. 3, p. 295, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Brusic, G. Rudy, and L. C. Harrison, “MHCPEP, a database of MHC-binding peptides: update 1997,” Nucleic Acids Research, vol. 26, no. 1, p. 368, 1998. View at Google Scholar
  17. H. Rammensee, J. Bachmann, N. P. Emmerich, O. A. Bachor, and S. Stevanovic, “SYFPEITHI: database for MHC ligands and peptide motifs,” Immunogenetics, vol. 50, no. 3-4, p. 213, 1999. View at Google Scholar
  18. C. C. Wilson, D. McKinney, M. Anders et al., “Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1,” Journal of Immunology, vol. 171, no. 10, p. 5611, 2003. View at Google Scholar
  19. D. N. Bourdette, E. Edmonds, C. Smith et al., “A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis,” Multiple Sclerosis, vol. 11, no. 5, p. 552, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. H. L. Robinson and R. R. Amara, “T cell vaccines for microbial infections,” Nature Medicine, vol. 11, article S25, Supplement 4, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Lopez, C. Weilenman, R. Audran et al., “A synthetic malaria vaccine elicits a potent CD8+ and CD4+ T lymphocyte immune response in humans. Implications for vaccination strategies,” European Journal of Immunology, vol. 31, no. 7, p. 1989, 2001. View at Publisher · View at Google Scholar
  22. D. A. Benson, K. Clark, I. Karsch-Mizrachi, D. J. Lipman, J. Ostell, and E. W. Sayers, “GenBank,” Nucleic Acids Research, vol. 43, article D30, Database issue, 2008. View at Google Scholar
  23. I. A. Doytchinova and D. R. Flower, “VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines,” BMC Bioinformatics, vol. 8, p. 4, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. F. Altschul, W. Gish, W. Miller, E. W. Myers, and D. J. Lipman, “Basic local alignment search tool,” Journal of Molecular Biology, vol. 215, no. 3, p. 403, 1990. View at Publisher · View at Google Scholar
  25. F. Chen, A. J. Mackey, C. J. Stoeckert Jr., and D. S. Roos, “OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups,” Nucleic Acids Research, vol. 34, article D363, Database issue, 2006. View at Publisher · View at Google Scholar
  26. S. P. Singh, K. Roopendra, and B. N. Mishra, “Genome-wide prediction of vaccine candidates for Leishmania major: an integrated approach,” Journal of Tropical Medicine, vol. 2015, Article ID 709216, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. A. R. Oany, A. A. Emran, and T. P. Jyoti, “Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach,” Drug Design, Development and Therapy, vol. 8, p. 1139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. A. R. Oany, T. Sharmin, A. S. Chowdhury, T. P. Jyoti, and M. A. Hasan, “Highly conserved regions in Ebola virus RNA dependent RNA polymerase may be act as a universal novel peptide vaccine target: a computational approach,” In Silico Pharmacol, vol. 3, no. 1, p. 7, 2015. View at Publisher · View at Google Scholar
  29. M. V. Larsen, C. Lundegaard, K. Lamberth, S. Buus, O. Lund, and M. Nielsen, “Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction,” BMC Bioinformatics, vol. 8, p. 424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Buus, S. L. Lauemoller, P. Worning et al., “Sensitive quantitative predictions of peptide-MHC binding by a ‘Query by Committee’ artificial neural network approach,” Tissue Antigens, vol. 62, no. 5, p. 378, 2003. View at Google Scholar
  31. P. Wang, J. Sidney, C. Dow, B. Mothe, A. Sette, and B. Peters, “A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach,” PLoS Computational Biology, vol. 4, no. 4, article e1000048, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Wang, J. Sidney, Y. Kim et al., “Peptide binding predictions for HLA DR, DP and DQ molecules,” BMC Bioinformatics, vol. 11, p. 568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Thomsen, C. Lundegaard, S. Buus, O. Lund, and M. Nielsen, “MHCcluster, a method for functional clustering of MHC molecules,” Immunogenetics, vol. 65, no. 9, p. 655, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H. H. Bui, J. Sidney, W. Li, N. Fusseder, and A. Sette, “Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines,” BMC Bioinformatics, vol. 8, p. 361, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Garcia-Boronat, C. M. Diez-Rivero, E. L. Reinherz, and P. A. Reche, “PVS: a web server for protein sequence variability analysis tuned to facilitate conserved epitope discovery,” Nucleic Acids Research, vol. 36, article W35, Web Server issue, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. H. H. Bui, J. Sidney, K. Dinh, S. Southwood, M. J. Newman, and A. Sette, “Predicting population coverage of T-cell epitope-based diagnostics and vaccines,” BMC Bioinformatics, vol. 7, p. 153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Sali, L. Potterton, F. Yuan, H. van Vlijmen, and M. Karplus, “Evaluation of comparative protein modeling by MODELLER,” Proteins, vol. 23, no. 3, p. 318, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. R. A. Laskowski, J. A. Rullmannn, M. W. MacArthur, R. Kaptein, and J. M. Thornton, “AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR,” Journal of Biomolecular NMR, vol. 8, no. 4, p. 477, 1996. View at Google Scholar
  39. K. Arnold, L. Bordoli, J. Kopp, and T. Schwede, “The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling,” Bioinformatics, vol. 22, no. 2, p. 195, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. J. J. Ward, L. J. McGuffin, K. Bryson, B. F. Buxton, and D. T. Jones, “The DISOPRED server for the prediction of protein disorder,” Bioinformatics, vol. 20, no. 13, p. 2138, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Jenik, R. G. Parra, L. G. Radusky, A. Turjanski, P. G. Wolynes, and D. U. Ferreiro, “Protein frustratometer: a tool to localize energetic frustration in protein molecules,” Nucleic Acids Research, vol. 40, article W348, Web Server issue, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. O. Trott and A. J. Olson, “AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading,” Journal of Computational Chemistry, vol. 31, no. 2, p. 455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. H. M. Berman, J. Westbrook, Z. Feng et al., “The Protein Data Bank,” Nucleic Acids Research, vol. 28, no. 1, p. 235, 2000. View at Google Scholar
  44. P. Thevenet, Y. Shen, J. Maupetit, F. Guyon, P. Derreumaux, and P. Tuffery, “PEP-FOLD: an updated de novo structure prediction server for both linear and disulfide bonded cyclic peptides,” Nucleic Acids Research, vol. 40, article W288, Web Server issue, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. H. C. Muh, J. C. Tong, and M. T. Tammi, “AllerHunter: a SVM-pairwise system for assessment of allergenicity and allergic cross-reactivity in proteins,” PLoS One, vol. 4, no. 6, article e5861, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Liao and W. S. Noble, “Combining pairwise sequence similarity and support vector machines for detecting remote protein evolutionary and structural relationships,” Journal of Computational Biology, vol. 10, no. 6, p. 857, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. A. S. Kolaskar and P. C. Tongaonkar, “A semi-empirical method for prediction of antigenic determinants on protein antigens,” FEBS Letters, vol. 276, no. 1-2, p. 172, 1990. View at Google Scholar
  48. E. A. Emini, J. V. Hughes, D. S. Perlow, and J. Boger, “Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide,” Journal of Virology, vol. 55, no. 3, p. 836, 1985. View at Google Scholar
  49. J. M. Parker, D. Guo, and R. S. Hodges, “New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites,” Biochemistry, vol. 25, no. 19, p. 5425, 1986. View at Google Scholar
  50. D. A. Rowe-Magnus and D. Mazel, “The role of integrons in antibiotic resistance gene capture,” International Journal of Medical Microbiology, vol. 292, no. 2, p. 115, 2002. View at Publisher · View at Google Scholar
  51. K. Goh, D. Chua, B. Beck, M. L. McKee, and A. A. Bhagwat, “Arginine-dependent acid-resistance pathway in Shigella boydii,” Archives of Microbiology, vol. 193, no. 3, p. 179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Walker, “New possibilities for the development of a combined vaccine against ETEC and Shigella,” BMJ Global Health, vol. 1, Supplement 2, no. 2, article A11, 2017. View at Google Scholar
  53. M. S. Riddle, R. W. Kaminski, C. Di Paolo et al., “Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella flexneri 2a administered to healthy adults: a single-blind, randomized phase I study,” Clinical and Vaccine Immunology, vol. 23, no. 12, p. 908, 2016. View at Publisher · View at Google Scholar
  54. M. S. Riddle, R. W. Kaminski, C. Williams et al., “Safety and immunogenicity of an intranasal Shigella flexneri 2a invaplex 50 vaccine,” Vaccine, vol. 29, no. 40, p. 7009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. Q. Jin, Z. Yuan, J. Xu et al., “Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157,” Nucleic Acids Research, vol. 30, no. 20, p. 4432, 2002. View at Google Scholar
  56. R. Bacchetta, S. Gregori, and M. G. Roncarolo, “CD4+ regulatory T cells: mechanisms of induction and effector function,” Autoimmunity Reviews, vol. 4, no. 8, p. 491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. J. U. Igietseme, F. O. Eko, Q. He, and C. M. Black, “Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens,” Expert Review of Vaccines, vol. 3, no. 1, p. 23, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Shrestha and M. S. Diamond, “Role of CD8+ T cells in control of West Nile virus infection,” Journal of Virology, vol. 78, no. 15, p. 8312, 2004. View at Publisher · View at Google Scholar · View at Scopus